Included were 664,159 women; of these, 22,938 had hyperlipidemia and 9,312 had breast cancer.
What does HLD stand for?
HLD stands for Hyperlipidemia
This definition appears frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of HLD
We have 43 other meanings of HLD in our Acronym Attic
- High Level Discrete (command type)
- High Lift Device (aviation)
- High-Level Dialogue
- High-Level Disinfection
- Hold (baseball relief pitcher statistic)
- Holdrege (Amtrak station code; Holdrege, NE)
- Homeland Defense (US)
- Horny Little Devil
- Howard Lindley Desings (Second Life shop)
- Human Lawn Dart (bicycling)
- Hypersensitivity Lung Disease
- Hamilton Local Digital Academy (Ohio)
- HANYS Long Distance Alliance (HANYS Solutions)
- Heteroscedastic Linear Discriminant Analysis
- High Level Design Automation
- High Level Detection Alarm
- Highway Loss Data Institute
- Hold Acknowledge
- Holland Library Data Archive (Washington State University)
- Homeschool Legal Defense Association (also seen as HSLDA)
Samples in periodicals archive:
Tart cherries are a rich source of anthocyanins, and whole cherry fruit intake may also affect hyperlipidemia and/or affect tissue PPARs.
2) As a result of this study, the National Cholesterol Education Program published a series of recommendations regarding screening children for hyperlipidemia in 1992 that was adopted by the American Academy of Pediatrics.
Suzan Gharaibeh, a doctor from Abu Hammour Medical Center and a specialist in endocrinology, diabetes and metabolism says hyperlipidemia is caused when your diet contains too much cholesterol and fat from foods such as meat, cheese, cream, eggs or shellfish.
Likewise, 20% had a diagnosis of hyperlipidemia at baseline; another 6% met the criteria but were undiagnosed.
Davignon and Dufour are both affiliated with the Hyperlipidemia and Atherosclerosis Research Group at the Clinical Research Institute of Montreal, Canada.
Research: Researchers performed a multicenter, randomized, placebo-controlled, parallel-group trial of 143 patients with hypercholesterolemia or combined hyperlipidemia having a baseline LDL cholesterol of 150 mg/dl and either no or one cardiovascular risk factor other than known coronary heart disease, or baseline LDL-C levels of between 150 and 189 mg/dl and two or more risk factors.
J-LIT, which covers approximately 50,000 hyperlipidemia patients in Japan, is designed to examine the correlations among the administration of simvastatin, serum lipid levels, and risk of ischemic disorder.